Adiponectin inhibits fat accumulation in hepatocytes and inhibits progression to NASH by controlling the activation of hepatic stellate cells through AMPK [13, 14]. This evidence concerns the gene ADIPOQ and metabolic dysfunction-associated steatohepatitis.